PRESCRIBING · PART D · 2024
Total Rx claims
1,254
Beneficiaries
—
Total drug cost
$579K
Distinct drugs
26
Brand share
70.9%
Top prescribed drugs
Fluticasone/Umeclidin/Vilanter341 claims
Albuterol Sulfate183 claims
Fluticasone/Vilanterol60 claims
Umeclidinium Brm/Vilanterol Tr58 claims
Montelukast Sodium53 claims
QUALITY · MIPS · 2024
Final MIPS score
93.9
Quality
85.0
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.80%
APM Entity
CROSS-REFERENCE